ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SGMO Sangamo Therapeutics Inc

0.645
0.0203 (3.25%)
Mar 28 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,264,612
Bid Price 0.645
Ask Price 0.6548
News -
Day High 0.6734

Low
0.2911

52 Week Range

High
1.8199

Day Low 0.62
Company Name Stock Ticker Symbol Market Type
Sangamo Therapeutics Inc SGMO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0203 3.25% 0.645 19:59:47
Open Price Low Price High Price Close Price Prev Close
0.625 0.62 0.6734 0.6702 0.6247
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,762 1,264,612 $ 0.645896 $ 816,808 - 0.2911 - 1.8199
Last Trade Time Type Quantity Stock Price Currency
19:59:47 formt 635 $ 0.645 USD

Sangamo Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
119.87M 178.91M - 111.3M -192.28M -1.07 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Sangamo Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SGMO Message Board. Create One! See More Posts on SGMO Message Board See More Message Board Posts

Historical SGMO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.840.97820.5910.70721923,384,530-0.195-23.21%
1 Month1.111.190.5910.83198822,295,245-0.465-41.89%
3 Months0.53781.480.390.84395692,417,9790.107219.93%
6 Months0.6011.480.29110.66008592,220,2400.0447.32%
1 Year1.741.81990.29110.95266492,146,209-1.10-62.93%
3 Years11.9812.850.29113.801,625,055-11.34-94.62%
5 Years9.0919.430.29116.781,731,830-8.45-92.90%

Sangamo Therapeutics Description

Sangamo Therapeutics Inc is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemophilia, Central Nervous System, HIV, Lysosomal Storage Disorders, and Hemoglobinopathies.

Your Recent History

Delayed Upgrade Clock